MedPath

Clinical Evaluation of Effect of Agnichikitsa, Virechana (medicated purgation) and Ekangaveera Rasa in Pakshaghata (Paralysis)

Phase 2
Conditions
Health Condition 1: G819- Hemiplegia, unspecified
Registration Number
CTRI/2024/03/064264
Lead Sponsor
Dean Faculty of Ayurved Parul University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Haemodynamically stable patients of Pakshaghata (Cerebro-vascular accident) after settle down of the initial emergency condition

Exclusion Criteria

1)Uncontrolled Malignant Hypertension

2)Uncontrolled Diabetes Mellitus

3)Dyslipidemia

4)Intracranial tumours

5)Cerebral Malignancy

6)Cerebral atrophy

7)Motor neuron disease

8)Guillian barre syndrome

9)Cerebral injuries

10)Recurrent and more than one year

11)Associated with major organic and infective pathologies

12)Pregnancy and lactating mother

13)Immune compromised patients HIV AIDS

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Compare the effect of Agnichikitsa, Virechana and Ekangaveera rasa with conventional management of Pakshaghata (Cerebro-vascular accident) assessing the values using FUGL-MEYER Assessment BERG Balance Scale and BARTHEL Index <br/ ><br>Timepoint: At baseline and on 15th 30th 45th 60th 75th and on 90th day
Secondary Outcome Measures
NameTimeMethod
Compare the effect of Agnichikitsa, Virechana and Ekangaveera rasa with conventional management of Pakshaghata (Cerebro-vascular accident) on the basis of FUGL-MEYER Assessment, BERG Balance Scale and BARTHEL Index. Evaluate the safety of the treatment.Timepoint: At baseline and on 15th 30th 45th 60th 75th and on 90th day
© Copyright 2025. All Rights Reserved by MedPath